BioNexus Gene Lab Files for Nasdaq New Listing, $17 Million Offering (OTCMKTS:BGLC)

3D Word IPO with target on board background - 3D rendering


BioNexus Gene Lab ( OTCPK:BGLC ), a wholesaler of chemical raw materials and developer of liquid biopsy tests, has filed to list its shares on the Nasdaq and raised $17 million through an offering.

BioNexus did not provide a number in its applicationschedule of application fees

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *